Invitation-only working summit convenes FDA, CMS, and industry leaders April 10 in Charlotte, North Carolina. This call ...

MS meditation, whether through mindfulness, breathwork, or guided walking, can help you manage the stress of living with the disease.

Neuroimmune diseases, such as multiple sclerosis, myasthenia gravis, and autoimmune encephalitis, are debilitating conditions ...

About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and ...

MS is currently treated with 'disease-modifying' medicines (e.g. interferon beta, glatiramer acetate, natalizumab, fingolimod, alemtuzumab, teriflunomide, and dimethyl fumarate). These medicines can ...

A Territory mother-of-four was exposed to a “catastrophic chain of failures” that claimed her life following what was meant ...

The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...

Clinical outcomes from routine practice confirm ocrelizumab effectiveness in relapsing MS, with low rates of disability worsening over 4 years.

Kavita Mehta is pinning her hopes on 2026 for a cure to a major blood disorder, following a breakthrough gene-editing treatment on the NHS. Ms Mehta, 36, from London, suffers from beta thalassaemia, a ...

Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...

Last month, the FDA declined to approve Sanofi’s tolebrutinib for a specific form of multiple sclerosis. In a recently ...

For the first time, UCL researchers have used AI to identify two biologically distinct forms of multiple sclerosis ...